|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Colin. 71:209–249. 2021.
View Article : Google Scholar
|
|
2
|
Meyerhardt JA and Mayer RJ: Systemic
therapy for colorectal cancer. N Engl J Med. 352:476–487. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sinicrope FA, Foster NR, Thibodeau SN,
Marsoni S, Monges G, Labianca R, Kim GP, Yothers G, Allegra C,
Moore MJ, et al: DNA mismatch repair status and colon cancer
recurrence and survival in clinical trials of 5-fluorouracil-based
adjuvant therapy. J Natl Cancer Inst. 103:863–875. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Visvader JE and Lindeman GJ: Cancer stem
cells: Current status and evolving complexities. Cell Stem Cell.
10:717–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zeuner A, Todaro M, Stassi G and De Maria
R: Colorectal cancer stem cells: from the crypt to the clinic. Cell
Stem Cell. 15:692–705. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aranburu A, Liberg D, Honoré B and
Leanderson T: CArG box-binding factor-A interacts with multiple
motifs in immunoglobulin promoters and has a regulated subcellular
distribution. Eur J Immunol. 36:2192–2202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fomenkov A, Huang YP, Topaloglu O,
Brechman A, Osada M, Fomenkova T, Yuriditsky E, Trink B, Sidransky
D and Ratovitski E: P63 alpha mutations lead to aberrant splicing
of keratinocyte growth factor receptor in the Hay-Wells syndrome. J
Biol Chem. 278:23906–23914. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mao Y, Tamura T, Yuki Y, Abe D, Tamada Y,
Imoto S, Tanaka H, Homma H, Tagawa K, Miyano S and Okazawa H: The
hnRNP-Htt axis regulates necrotic cell death induced by
transcriptional repression through impaired RNA splicing. Cell
Death Dis. 7:e22072016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tauler J, Zudaire E, Liu H, Shih J and
Mulshine JL: hnRNP A2/B1 modulates epithelial-mesenchymal
transition in lung cancer cell lines. Cancer Res. 70:7137–7147.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hua JT, Ahmed M, Guo H, Zhang Y, Chen S,
Soares F, Lu J, Zhou S, Wang M, Li H, et al: Risk SNP-mediated
promoter-enhancer switching drives prostate cancer through lncRNA
PCAT19. Cell. 174:564–575.e18. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Y, Chen Q, Piao HY, Wang B, Zhu GQ,
Chen EB, Xiao K, Zhou ZJ, Shi GM, Shi YH, et al: HNRNPAB-regulated
lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinoma.
Int J Cancer. 146:169–180. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou ZJ, Dai Z, Zhou SL, Hu ZQ, Chen Q,
Zhao YM, Shi YH, Gao Q, Wu WZ, Qiu SJ, et al: HNRNPAB induces
epithelial-mesenchymal transition and promotes metastasis of
hepatocellular carcinoma by transcriptionally activating SNAIL.
Cancer Res. 74:2750–2762. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou JM, Jiang H, Yuan T, Zhou GX, Li XB
and Wen KM: High hnRNP AB expression is associated with poor
prognosis in patients with colorectal cancer. Oncol Lett.
18:6459–6468. 2019.PubMed/NCBI
|
|
14
|
Zhou JM, Hu SQ, Jiang H, Chen YL, Feng JH,
Chen ZQ and Wen KM: OCT4B1 promoted EMT and regulated the
self-renewal of CSCs in CRC: Effects associated with the balance of
miR-8064/PLK1. Mol Ther Oncolytics. 15:7–20. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu X, Su K, Sun X, Jiang Y, Wang L, Hu C,
Zhang C, Lu M, Du X and Xing B: Sec62 promotes stemness and
chemoresistance of human colorectal cancer through activating
Wnt/β-catenin pathway. J Exp Clin Cancer Res. 40:1322021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu Y, Wang X, Gu Q, Wang J, Sui Y, Wu J
and Feng J: Heterogeneous nuclear ribonucleoprotein A/B: An
emerging group of cancer biomarkers and therapeutic targets. Cell
Death Discov. 8:3372022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han SP, Tang YH and Smith R: Functional
diversity of the hnRNPs: Past, present and perspectives. Biochem J.
430:379–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lobo NA, Shimono Y, Qian D and Clarke MF:
The biology of cancer stem cells. Annu Rev Cell Dev Biol.
23:675–699. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilson BJ, Schatton T, Zhan Q, Gasser M,
Ma J, Saab KR, Schanche R, Waaga-Gasser AM, Gold JS, Huang Q, et
al: ABCB5 identifies a therapy-refractory tumor cell population in
colorectal cancer patients. Cancer Res. 71:5307–5316. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang TY, Lan KC, Chiu CY, Sheu ML and Liu
SH: ANGPTL1 attenuates cancer migration, invasion, and stemness
through regulating FOXO3a-mediated SOX2 expression in colorectal
cancer. Clin Sci (Lond). 136:657–673. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wen K, Fu Z, Wu X, Feng J, Chen W and Qian
J: Oct-4 is required for an antiapoptotic behavior of
chemoresistant colorectal cancer cells enriched for cancer stem
cells: Effects associated with STAT3/survivin. Cancer Lett.
333:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kantara C, O'Connell M, Sarkar S, Moya S,
Ullrich R and Singh P: Curcumin promotes autophagic survival of a
subset of colon cancer stem cells, which are ablated by
DCLK1-siRNA. Cancer Res. 74:2487–2498. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park SY, Kim JY, Jang GB, Choi JH, Kim JH,
Lee CJ, Lee S, Baek JH, Park KK, Kim JM, et al: Aberrant activation
of the CD45-Wnt signaling axis promotes stemness and therapy
resistance in colorectal cancer cells. Theranostics. 11:8755–8770.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Beck B and Blanpain C: Unravelling cancer
stem cell potential. Nature reviews. Cancer. 13:727–738.
2013.PubMed/NCBI
|
|
27
|
Choi HS, Lee HM, Jang YJ, Kim CH and Ryu
CJ: Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the
self-renewal and pluripotency of human embryonic stem cells via the
control of the G1/S transition. Stem Cells. 31:2647–2658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen ZQ, Yuan T, Jiang H, Yang YY, Wang L,
Fu RM, Luo SQ, Zhang T, Wu ZY and Wen KM: MicroRNA-8063 targets
heterogeneous nuclear ribonucleoprotein AB to inhibit the
self-renewal of colorectal cancer stem cells via the Wnt/β-catenin
pathway. Oncol Rep. 46:2192021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen X, Wang C, Jiang Y, Wang Q, Tao Y,
Zhang H, Zhao Y, Hu Y, Li C, Ye D, et al: Bcl-3 promotes Wnt
signaling by maintaining the acetylation of β-catenin at lysine 49
in colorectal cancer. Signal Transduct Target Ther. 5:522020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Konishi H, Fujiya M, Kashima S, Sakatani
A, Dokoshi T, Ando K, Ueno N, Iwama T, Moriichi K, Tanaka H and
Okumura T: A tumor-specific modulation of heterogeneous
ribonucleoprotein A0 promotes excessive mitosis and growth in
colorectal cancer cells. Cell Death Dis. 11:2452020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu H, Li D, Sun L, Qin H, Fan A, Meng L,
Graves-Deal R, Glass SE, Franklin JL, Liu Q, et al: Interaction of
lncRNA MIR100HG with hnRNPA2B1 facilitates m6A-dependent
stabilization of TCF7L2 mRNA and colorectal cancer progression. Mol
Cancer. 21:742022. View Article : Google Scholar : PubMed/NCBI
|
